Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations

J Clin Microbiol. 2005 Jun;43(6):2991-3. doi: 10.1128/JCM.43.6.2991-2993.2005.

Abstract

We evaluated the COBAS Ampliscreen hepatitis B virus (HBV) test using standards, seroconversion panels, consecutive donations, and samples from patients with abnormal alanine aminotransferase and chronic hepatitis C. Specificity was 100% and sensitivity was 20 IU/ml. In seroconversion panels, HBV DNA was detected up to 4 to 18 days before HBsAg, suggesting that this assay is useful in shortening the infectious window phase.

Publication types

  • Evaluation Study
  • Multicenter Study

MeSH terms

  • Blood Donors*
  • DNA, Viral / blood*
  • Hepatitis B / diagnosis*
  • Hepatitis B / virology
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / isolation & purification*
  • Humans
  • Nucleic Acid Amplification Techniques / methods*
  • Nucleic Acid Amplification Techniques / standards
  • Polymerase Chain Reaction / instrumentation
  • Polymerase Chain Reaction / methods
  • Sensitivity and Specificity

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens